Fp-1039 has a dramatic inhibitory effect on head and neck squamous cell carcinoma overexpressing FGF2, but has no effect on squamous cell carcinoma with low FGF2 expression [22]. This evidence concerns the gene FGF2 and head and neck squamous cell carcinoma.